GUTS
HealthcareFractyl Health, Inc.
$2.06
$-0.19 (-8.44%)
Jan 5, 2026
Price History (1Y)
Analysis
Fractyl Health, Inc. (GUTS) is a biotechnology company in the healthcare sector with a market capitalization of $282.31 million and 101 employees. It has generated revenue of $3,000 over the past four quarters. The financial health of Fractyl Health, Inc. is marked by significant losses. The company's net income for the past four quarters stands at -$122,197,000, while its EBITDA is -$97,669,000. Free cash flow has also been negative at -$49,940,752. However, the company maintains a gross margin of 100.0% and a current ratio of 4.27. Its return on equity is -518.4%, and return on assets is -51.2%. The company's balance sheet shows $77.66 million in cash and $62.18 million in debt. The valuation of Fractyl Health, Inc. is reflected in its negative price-to-earnings ratio (-2.93) and price-to-book value (-85.83). Its forward price-to-earnings ratio is also negative at -3.00. The company's price to sales ratio stands at 94,103.85, indicating a high valuation relative to revenue.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Fractyl Health, Inc.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $282.31M
- P/E Ratio
- N/A
- 52-Week High
- $3.03
- 52-Week Low
- $0.82
- Avg Volume
- 2.84M
Company Info
- Industry
- Biotechnology
- Exchange
- NGM
- Country
- United States
- Employees
- 101